GENReports: Market & Tech Analysis

Size: px
Start display at page:

Download "GENReports: Market & Tech Analysis"

Transcription

1 GENReports: Market & Tech Analysis > Gary Oosta, Ph.D. Biotechnology Analyst, Select Biosciences, Inc. > Enal Razvi, Ph.D. Managing Director Select Biosciences, Inc. GENReports: Market & Tech Analysis, Produced by Oosta and Razvi 2015

2 Deep Analysis of Exosomes Marketplace from the BoBom- Up Scope of this Report: There is the unmet need to characterize the dynamics of the exosomes and broader extracellular vesicles marketplace as it is rapidly evolving and highly granular with lots of market segments Select Biosciences has been tracking this field for the past several years and our conenuing industry coverage allows us to pinpoint trends in this space In this report, we present a snapshot of this complex space and map its evolueon this is part I of a three- part report in this part I we present the macro landscape of exosomes We Present Here: An overall landscape of Exosome publicaeon acevity Trends in specific segments within the exosome landscape An ideneficaeon of segments (disease classes, tools and methods in exosome research) that are responsible for growth Data and Analysis are up- to- date as of June 2015

3 Based on PublicaUon AcUvity, Interest in Exosomes is Growing at a Nearly ExponenUal Pace We will focus the analysis presented here on the years , where the publicaeon rates are highest.

4 The Exosome Space is Composed of 35,730 PublicaUons The Exosomes Word Cloud: A Picture is &W orth a Thousand Words GENReports: Market Tech Analysis, Produced by Oosta and Razvi 2015

5 Trends in Exosome Terminology suggests that the Overlapping Terminology Star%ng to Clarify Exosome Extracellular Vesicle One Metric for the EvoluEon/MaturaEon of the Exosomes Field is the Clarity of Nomenclature

6 Trends in DetecUon Methods for Exosome Research in the Academic Literature. Flow Cytometry: Growing in Penetrance GENReports: in Market the Exosomes & Tech Analysis, Space Produced by Oosta and Razvi 2015 Analysis of Individual Exosomes and Exosome Subsets Defined by Surface Phenotype

7 Trends in Tool Usage for Exosome Research in the Academic Literature Expanding Segments Flow Cytometry Western BloYng Imaging Mass Spectrometry UltracentrifugaEon

8 PCR remains a Key Tool: qpcr is an Emerging trend in Exosome Research The InterrogaUon of RNA Cargo in Exosomes

9 Micro- & Nano- in Exosomes The Impact of Microfluidics on Exosome Research is SEll Small We however believe that the InterrogaEon of CirculaUng Biomarkers via Microfluidics, Lab- on- a- Chip Approaches will ConsEtute an Emerging Theme Going Forward

10 Exosome Research Market SegmentaUon by Biofluid Class Top Classes Blood Plasma Serum Emerging Biofluid Classes Various Biofluid Classes Enable the Development of Biofluid Biopsies (Liquid Biopsies)

11 Next- Gen Sequencing & Whole Genome Amp. Surprisingly Limited Impact on Exosome Research to Date NGS: Only Beginning to Impact Exosome Research Whole Genome Analysis: Not Applicable GENReports: since Market Exosomes & Tech Analysis, Don t Produced Carry by Oosta the and Whole Razvi Genome 2015

12 Classes of Cargo Analyzed in Exosomes Nucleic Acids and Proteins are the Top Currently EpigeneEc Analyses and Lipid Analyses are Nascent

13 Conclusions and Outlook for the Field The analysis presented here is the most up- to- date market analysis of the exosomes space this is the first of 3 reports we will be publishing on this topic Given the fact that the exosomes field is highly- fragmented across several thousand researchers over several conenents, the only way to analyze the field en bloc is to study the enere current academic literature in the field and then draw conclusions based on trends operaeve therein Our system has enabled us to analyze all of the 35,730 publicaeons that together comprise the extracellular vesicles (EV) field therefore, we can view major trends as well as minueae as they are developing We document the expansion of specific methodologies such as flow cytometry that are expanding in penetrance in the exosomes field We also analyze here the various analyte classes that are being studied in the exosomes space some of these analytes today represent circulaeng biomarkers of the future

14 Select Biosciences bring all the key opinion leaders (KOLs) in the Liquid Biopsies Space Together Focus on Exosomes, CirculaUng DNA, CirculaUng RNA, CirculaUng Tumor Cells (CTCs) For More InformaEon About the Conference, Please Scan the QR Code to the Right with your Mobile Device (iphone, ipad, Android) For More InformaUon, Please Contact:

GENReports: Market & Tech Analysis

GENReports: Market & Tech Analysis GENReports: Market & Tech Analysis > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director Select Biosciences, Inc. enal@selectbio.us! The,focus,of,this,GEN,Market,&,Tech,Analysis,Report,is,to,frame,a,

More information

microrna Therapeutics Heading Towards the Clinic

microrna Therapeutics Heading Towards the Clinic GENReports: Market & Tech Analysis microrna Therapeutics Heading Towards the Clinic > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director SELECTBIO US enal@selectbio.us Topic Introduction and Scope

More information

Exosomes, Extracellular Vesicles A Technology Review

Exosomes, Extracellular Vesicles A Technology Review Exosomes, Extracellular Vesicles A Technology Review 1 Author, Data Collection Date, Notes The Author Gary M. Oosta, holds a Ph.D. in Biophysics from Massachusetts Institute of Technology and a B.A. in

More information

Service and Collaboration

Service and Collaboration Summary Section 7 Introduction 68 Exosome and Microvesicle Isolation 69 EV protein quantification, sceening and profiling 69 Nanoparticle Tracking Analysis (NTA) 70 EV Nucleic Acid isolation 70 Nucleic

More information

micrornas!as! Biomarkers! Landscape!

micrornas!as! Biomarkers! Landscape! GENReports: Market & Tech Analysis micrornas!as! Biomarkers! Landscape! > Enal Razvi, Ph.D. Managing Director Select Biosciences, Inc. enal@selectbio.us! Topic Introduction and Scope! The,focus,of,this,GEN,Market,&,Tech,Analysis,Report,is,to,provide,

More information

Importance of Methodology Certification and Accreditations to Perform Assays. Stan Hamilton, MD Head, Pathology and Laboratory Medicine

Importance of Methodology Certification and Accreditations to Perform Assays. Stan Hamilton, MD Head, Pathology and Laboratory Medicine Importance of Methodology Certification and Accreditations to Perform Assays Stan Hamilton, MD Head, Pathology and Laboratory Medicine 1 Disclosures No disclosures relevant to this presentation 2 A bad

More information

Circulating Tumor Cells (CTC) Technologies

Circulating Tumor Cells (CTC) Technologies Table of Contents MIR036 I. SCOPE AND METHODOLOGY Scope of the Study Analytics and data presented in this report pertain to several parameters such as - Research Methodology This report is uniquely researched

More information

AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits

AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits Accelerating clinical research Next-generation sequencing (NGS) has the ability to interrogate many different genes and detect

More information

Extracellular Vesicle RNA isolation Kits

Extracellular Vesicle RNA isolation Kits Extracellular Vesicle RNA isolation Kits Summary Section 4 Introduction 42 Exo-TotalRNA and TumorExo-TotalRNA isolation kits 43 Extracellular Vesicle RNA extraction kits Ordering information Products can

More information

Exosome DNA Extraction Kits

Exosome DNA Extraction Kits Exosome DNA Extraction Kits Summary Section 5 Introduction 40 EXO-DNAc 41 EXO-DNA 43 Introduction Genomic DNA Extractiom Kits Ordering informations Products can be purchased directly in our on-line shop:

More information

Characteristics of Cancer Stem Cells (CSCs)

Characteristics of Cancer Stem Cells (CSCs) GENReports: Market & Tech Analysis Characteristics of Cancer Stem Cells (CSCs) > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director Select Biosciences, Inc. enal@selectbio.us! Topic,IntroducEon,and,Scope!

More information

SURVEY REPORT CLINICAL TRIALS: PAST, PRESENT AND FUTURE

SURVEY REPORT CLINICAL TRIALS: PAST, PRESENT AND FUTURE SURVEY REPORT CLINICAL TRIALS: PAST, PRESENT AND FUTURE + OVERVIEW Clinical trials have changed dramatically in the last 10 years. Sponsors are increasingly pressured to get drugs to market faster and

More information

Clinical Liquid Biopsy Explained: Applications, Techniques and Players

Clinical Liquid Biopsy Explained: Applications, Techniques and Players Volume XX, Issue 3 Clinical Liquid Biopsy Explained: Applications, Techniques and Players A minimally invasive diagnostic that can help clinicians detect, diagnose and manage cancer patients has long been

More information

REFERENCE CODE GDHC1161DFR PUBLICAT ION DATE SEPTEMBER 2013 MENOMUNE (MENINGOCOCCAL VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC1161DFR PUBLICAT ION DATE SEPTEMBER 2013 MENOMUNE (MENINGOCOCCAL VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC1161DFR PUBLICAT ION DATE SEPTEMBER 2013 MENOMUNE (MENINGOCOCCAL VACCINES) - Executive Summary Menomune: Key Metrics in the Nine Major Pharmaceutical Markets 2012 Market Sales US 5EU

More information

REFERENCE CODE GDHC1155DFR PUBLICAT ION DATE SEPTEMBER 2013 NIMENRIX (MENINGOCOCCAL VACCINES) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC1155DFR PUBLICAT ION DATE SEPTEMBER 2013 NIMENRIX (MENINGOCOCCAL VACCINES) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC1155DFR PUBLICAT ION DATE SEPTEMBER 2013 NIMENRIX (MENINGOCOCCAL VACCINES) Executive Summary Nimenrix: Key Metrics in the Nine Major Pharmaceutical Markets 2012 Market Sales US 5EU Japan

More information

Innovations in nucleic acid amplification technologies. Automated platforms for NAT. Microfluidics Digital PCR Innovations in nucleic acid microarrays

Innovations in nucleic acid amplification technologies. Automated platforms for NAT. Microfluidics Digital PCR Innovations in nucleic acid microarrays About the author Disclaimer EXECUTIVE SUMMARY Molecular diagnostic technologies Healthcare-associated infections Sexually transmitted HPVs HIV and hepatitis viruses Market outlook and forecasts Molecular

More information

PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM

PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM HEMATOLOGY ONCOLOGY PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM COMMITTED TO ADVANCING DRUG DEVELOPMENT IN ONCOLOGY $ MARKETPLACE COMPLEXITIES increasingly competitive marketplace and rising cost pressures

More information

Liquid Biopsies. Next Generation Cancer Molecular Diagnostics

Liquid Biopsies. Next Generation Cancer Molecular Diagnostics Liquid Biopsies Next Generation Cancer Molecular Diagnostics Forward Looking Statements 2 Statements pertaining to future financial and/or operating results, future research, diagnostic tests and technology

More information

North America Cardiac Rhythm Management (CRM) Procedures Outlook to 2021

North America Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 North America Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 North America Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 BioPortfolio has been marketing business and market research

More information

Present and future for clinical applications of extracellular vesicles

Present and future for clinical applications of extracellular vesicles Present and future for clinical applications of extracellular vesicles Natasa Zarovni, Exosomics Siena SpA, Italy xxxxxxxxxxxxxxxxxxx Exosomes have come a long way..as for many misunderstood geniuses,

More information

Russia Cardiac Assist Devices Market Outlook to 2021

Russia Cardiac Assist Devices Market Outlook to 2021 Russia Cardiac Assist Devices Market Outlook to 2021 Russia Cardiac Assist Devices Market Outlook to 2021 BioPortfolio has been marketing business and market research reports from selected publishers for

More information

Bariatric Surgery Devices - North America Analysis and Market Forecasts

Bariatric Surgery Devices - North America Analysis and Market Forecasts Bariatric Surgery Devices - North America Analysis and Market Forecasts Bariatric Surgery Devices - North America Analysis and Market Forecasts BioPortfolio has been marketing business and market research

More information

2018 Edition The Current Landscape of Genetic Testing

2018 Edition The Current Landscape of Genetic Testing 2018 Edition The Current Landscape of Genetic Testing Market growth, reimbursement trends, challenges and opportunities November April 20182017 EXECUTIVE SUMMARY Concert Genetics is a software and managed

More information

Global Continuous Positive Airway Pressure(CPAP) Devices Market Research Report - Forecast to 2027

Global Continuous Positive Airway Pressure(CPAP) Devices Market Research Report - Forecast to 2027 Report Information More information from: https://www.marketresearchfuture.com/reports/939 Global Continuous Positive Airway Pressure(CPAP) Devices Market Research Report - Forecast to 2027 Report / Search

More information

Production of Exosomes in a Hollow Fiber Bioreactor

Production of Exosomes in a Hollow Fiber Bioreactor Production of Exosomes in a Hollow Fiber Bioreactor John J S Cadwell, President and CEO, FiberCell Systems Inc INTRODUCTION Exosomes are small lipid membrane vesicles (80-120 nm) of endocytic origin generated

More information

Urine Biomarkers for Prostate Cancer Detection

Urine Biomarkers for Prostate Cancer Detection Urine Biomarkers for Prostate Cancer Detection Dr. Qun Lu Professor of Anatomy and Cell Biology Director, The Wooten Laboratory Brody School of Medicine Acknowledgement of Support Funding US National Institutes

More information

Liquid Biopsies for Managing Cancer Treatment: Biomarkers and Diagnostics

Liquid Biopsies for Managing Cancer Treatment: Biomarkers and Diagnostics Liquid Biopsies for Managing Cancer Treatment: Biomarkers and Diagnostics Joshua Matt Jackson, Ph.D. Soper Lab University of Kansas KU Chemistry Alumni Symposium May 19, 2017 Liquid Biopsies Microfluidic

More information

ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE

ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE AT KANTAR HEALTH, ONCOLOGY

More information

The roadmap towards the industrial and clinical applications of extracellular vesicles

The roadmap towards the industrial and clinical applications of extracellular vesicles The roadmap towards the industrial and clinical applications of extracellular vesicles Exosomes and EVs have come a long way: major scientific milestones timeline Means to frame the size and evolution

More information

LIQUID BIOPSY RESEARCH TOOLS, SERVICES AND DIAGNOSTICS: GLOBAL MARKETS

LIQUID BIOPSY RESEARCH TOOLS, SERVICES AND DIAGNOSTICS: GLOBAL MARKETS LIQUID BIOPSY RESEARCH TOOLS, SERVICES AND DIAGNOSTICS: GLOBAL MARKETS BIO150A January 2016 John Bergin Project Analyst ISBN: 1-62296-224-9 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA

More information

Sleep apnea devices Market Research Report- Global Forecast To 2022

Sleep apnea devices Market Research Report- Global Forecast To 2022 Report Information More information from: https://www.marketresearchfuture.com/reports/2061 Sleep apnea devices Market Research Report- Global Forecast To 2022 Report / Search Code: MRFR/HC/1529-HCRR Publish

More information

REFERENCE CODE GDHC207DFR PUBLICAT ION DATE JUNE 2013 GILOTRIF (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC207DFR PUBLICAT ION DATE JUNE 2013 GILOTRIF (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC207DFR PUBLICAT ION DATE JUNE 2013 GILOTRIF (NON-SMALL CELL LUNG CANCER) GILOTRIF (NON-SMALL CELL LUNG CANCER) - Executive Summary Gilotrif: Key Metrics in NSCLC Markets 2022 Gilotrif

More information

USE OF EXOSOMES IN TRANSLATIONAL AND CLINICAL RESEARCH. Eva Colás Ortega Postdoc researcher IRBLleida

USE OF EXOSOMES IN TRANSLATIONAL AND CLINICAL RESEARCH. Eva Colás Ortega Postdoc researcher IRBLleida USE OF EXOSOMES IN TRANSLATIONAL AND CLINICAL RESEARCH Eva Colás Ortega Postdoc researcher IRBLleida ecolas@irblleida.cat THERE ARE DIFFERENT TYPE OF VESICLES RELEASED BY CELLS MICROVESICLES Size: 100-1000nm

More information

Survey Results Q1. How would you best describe your organization?

Survey Results Q1. How would you best describe your organization? Survey Results Q1. How would you best describe your organization? Q2. How high would you rate the priority of Circulating Tumor Cells in you organization? Q3. What do you think is the biggest challenge

More information

Disruptive innovation in molecular diagnostics. Hilde Windels CEO Biocartis 25 March 2017

Disruptive innovation in molecular diagnostics. Hilde Windels CEO Biocartis 25 March 2017 Disruptive innovation in molecular diagnostics Hilde Windels CEO Biocartis 25 March 2017 1 One of the key innovations in healthcare in the last decade PERSONALISED MEDICINE or HIGH PRECISION MEDICINE From

More information

Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2019

Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2019 Reference Code: GDHC504PRT Publication Date: January 2013 Cytomegalovirus Infections: Key Metrics in Seven Major Pharmaceutical Markets 2012 Epidemiology* Prevalent population (CMV prevalent cases in general

More information

The feasibility of circulating tumour DNA as an alternative to biopsy for mutational characterization in Stage III melanoma patients

The feasibility of circulating tumour DNA as an alternative to biopsy for mutational characterization in Stage III melanoma patients The feasibility of circulating tumour DNA as an alternative to biopsy for mutational characterization in Stage III melanoma patients ASSC Scientific Meeting 13 th October 2016 Prof Andrew Barbour UQ SOM

More information

Myriad Genetics Corporate Presentation 06/13/2018

Myriad Genetics Corporate Presentation 06/13/2018 Myriad Genetics Corporate Presentation 06/13/2018 Copyright 2016 2018 Myriad Genetics, Inc., all rights reserved. www.myriad.com. 1 Forward Looking Statements Some of the information presented here today

More information

REFERENCE CODE GDHC199DFR PUBLICAT ION DATE JUNE 2013 XALKORI (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC199DFR PUBLICAT ION DATE JUNE 2013 XALKORI (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC199DFR PUBLICAT ION DATE JUNE 2013 XALKORI (NON-SMALL CELL LUNG CANCER) Executive Summary Xalkori (crizotinib): Key Metrics in NSCLC Markets 2012 Xalkori Sales US 5EU Japan China India

More information

QIAGEN Complete Solutions for Liquid Biopsy Molecular Testing

QIAGEN Complete Solutions for Liquid Biopsy Molecular Testing QIAGEN Complete Solutions for Liquid Biopsy Molecular Testing Christopher Swagell, PhD Market Development Manager, Advanced Molecular Pathology QIAGEN 1 Agenda QIAGEN Solid Tumor Testing and Liquid Biopsy

More information

Asia-Pacific Electrophysiology Market Outlook to 2020

Asia-Pacific Electrophysiology Market Outlook to 2020 Asia-Pacific Electrophysiology Market Outlook to 2020 Reference Code: GDMECR0114DB Publication Date: May 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 5 1.2 List of Figures...

More information

REFERENCE CODE GDHC282DFR PUBLICATION DATE OCTOBER 2013 BELVIQ (OBESITY) - FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC282DFR PUBLICATION DATE OCTOBER 2013 BELVIQ (OBESITY) - FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC282DFR PUBLICATION DATE OCTOBER 2013 BELVIQ (OBESITY) - Executive Summary Below table provides a summary of Belviq for obesity in the nine major pharmaceutical markets during the forecast

More information

SAMPLE. North America Propylene Industry Outlook to 2017 GDCH0615RDB/JAN 2013

SAMPLE. North America Propylene Industry Outlook to 2017 GDCH0615RDB/JAN 2013 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Reference Code: GDCH0615RDB Publication Date: January 2013 GlobalData. This report is a licensed product

More information

Blood Glucose Test Strip Market Research Report- Global Forecast till 2020

Blood Glucose Test Strip Market Research Report- Global Forecast till 2020 Report Information More information from: https://www.marketresearchfuture.com/reports/976 Blood Glucose Test Strip Market Research Report- Global Forecast till 2020 Report / Search Code: MRFR/MED/0470-CRR

More information

BRAINLAB ELEMENTS RADIOTHERAPY PLANNING

BRAINLAB ELEMENTS RADIOTHERAPY PLANNING BRAINLAB ELEMENTS RADIOTHERAPY PLANNING BUILD REACH AND RICHNESS BRAINLAB ELEMENTS Medical technology just got a whole lot easier and innovation is within reach with pre-planning software apps by Brainlab.

More information

REFERENCE CODE GDHC465DFR PUBLICAT ION DATE SEPTEMBER 2014 KADCYLA (HER2-POSITIVE BREAST CANCER) - FORECAST AND MARKET ANALYSIS TO 2023

REFERENCE CODE GDHC465DFR PUBLICAT ION DATE SEPTEMBER 2014 KADCYLA (HER2-POSITIVE BREAST CANCER) - FORECAST AND MARKET ANALYSIS TO 2023 REFERENCE CODE GDHC465DFR PUBLICAT ION DATE SEPTEMBER 2014 KADCYLA (HER2-POSITIVE BREAST CANCER) - Executive Summary The table below presents the key metrics for Kadcyla for human epidermal growth factor

More information

BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020

BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020 BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook Reference Code: GDMECR0130PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables...

More information

XCF TM COMPLETE Exosome and cfdna Isolation Kit (for Serum & Plasma)

XCF TM COMPLETE Exosome and cfdna Isolation Kit (for Serum & Plasma) XCF TM COMPLETE Exosome and cfdna Isolation Kit (for Serum & Plasma) Cat# XCF100A-1 User Manual Store kit components at +4ºC and +25ºC Version 1 2/2/2017 A limited-use label license covers this product.

More information

SAMPLE. Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

SAMPLE. Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0165BDB Publication Date: January 2013 GlobalData. This report

More information

The potential of South East Asia and India as the hub for vaccine studies

The potential of South East Asia and India as the hub for vaccine studies The potential of South East Asia and India as the hub for vaccine studies Angela Chen Therapeutic Strategy Lead 16 November 2017 Copyright 2017 IQVIA. All rights reserved. The potential of South East Asia

More information

REFERENCE CODE GDHC386DFR PUBLICAT ION DATE M ARCH 2014 GARDASIL (PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC386DFR PUBLICAT ION DATE M ARCH 2014 GARDASIL (PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC386DFR PUBLICAT ION DATE M ARCH 2014 GARDASIL (PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022 Executive Summary Gardasil: Key Metrics in Nine Major

More information

REFERENCE CODE GDHC1032FPR PUBLICAT ION DATE M ARCH 2014 PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES - CURRENT AND FUTURE PLAYERS

REFERENCE CODE GDHC1032FPR PUBLICAT ION DATE M ARCH 2014 PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES - CURRENT AND FUTURE PLAYERS REFERENCE CODE GDHC1032FPR PUBLICAT ION DATE M ARCH 2014 PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES - Executive Summary Human PapillomaVirus (HPV) Vaccine Sales Expected to Grow Modestly During the Forecast

More information

Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020

Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Reference Code: GDMECR0195DB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List

More information

AVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB

AVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB Analysis Kits Next-generation performance in liquid biopsies 2 Accelerating clinical research From liquid biopsy to next-generation

More information

Championing patients every step of the way

Championing patients every step of the way Championing patients every step of the way The majority of people living with a rare disease have no treatment for their condition. At Shire, we have long believed we have a unique opportunity to champion

More information

REFERENCE CODE GDHC198DFR PUBLICAT ION DATE JUNE 2013 TARCEVA (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC198DFR PUBLICAT ION DATE JUNE 2013 TARCEVA (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC198DFR PUBLICAT ION DATE JUNE 2013 TARCEVA (NON-SMALL CELL LUNG CANCER) Executive Summary Tarceva (erlotinib): Key Metrics in NSCLC Markets 2012 Tarceva Sales US 5EU Japan China India

More information

REFERENCE CODE GDME1086CFR PUBLICAT ION DATE FEBRUARY 2014 BIOPSY DEVICES APAC ANALYSIS AND MARKET FORECASTS

REFERENCE CODE GDME1086CFR PUBLICAT ION DATE FEBRUARY 2014 BIOPSY DEVICES APAC ANALYSIS AND MARKET FORECASTS REFERENCE CODE GDME1086CFR PUBLICAT ION DATE FEBRUARY 2014 BIOPSY DEVICES Executive Summary The table below provides an overview of the APAC biopsy devices market during the forecast period from 2013 2019.

More information

REFERENCE CODE GDME0188M AR PUBLICATION DATE FEBRUARY 2014 BIOPSY DEVICES - GLOBAL ANALYSIS AND MARKET FORECASTS

REFERENCE CODE GDME0188M AR PUBLICATION DATE FEBRUARY 2014 BIOPSY DEVICES - GLOBAL ANALYSIS AND MARKET FORECASTS REFERENCE CODE GDME0188M AR PUBLICATION DATE FEBRUARY 2014 BIOPSY DEVICES - Executive Summary The table below provides an overview of the global biopsy devices market during the forecast period from 2013

More information

Integrated platform for liquid biopsy-based personalized cancer medicine

Integrated platform for liquid biopsy-based personalized cancer medicine Integrated platform for liquid biopsy-based personalized cancer medicine Dr. Bernhard Polzer Fraunhofer ITEM-Regensburg Personalized Tumor Therapy Personalized cancer therapy Primary tumor single tumor

More information

SAMPLE. Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to Reference Code: GDME0166BDB

SAMPLE. Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to Reference Code: GDME0166BDB Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0166BDB Publication Date: January 2013 GlobalData. This report is a licensed product

More information

Cancer Biology and Immunology. Sponsorship CANCER BIOLOGY rd World Congress on. Don t count the days make the Days Count

Cancer Biology and Immunology. Sponsorship CANCER BIOLOGY rd World Congress on. Don t count the days make the Days Count CANCER BIOLOGY 2019 Sponsorship March 11-12, 2019 Milan, Italy 3 rd World Congress on Cancer Biology and Immunology Don t count the days make the Days Count http://cancerbiology.immunologycongress.org/

More information

Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers

Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers Gordon Blackshields Senior Bioinformatician Source BioScience 1 To Cancer Genetics Studies

More information

MagCapture Exosome Isolation Kit PS Q&A

MagCapture Exosome Isolation Kit PS Q&A MagCapture Exosome Isolation Kit PS Q&A Specifications and performance P.1 Comparison of the conventional method P.2 Operation methods and composition P.4 Amount of starting sample P.5 Analysis after exosomes

More information

IPA Advanced Training Course

IPA Advanced Training Course IPA Advanced Training Course October 2013 Academia sinica Gene (Kuan Wen Chen) IPA Certified Analyst Agenda I. Data Upload and How to Run a Core Analysis II. Functional Interpretation in IPA Hands-on Exercises

More information

Global E-Cigarette & Vaporizer Market Research Report - Forecast 2011 to 2021

Global E-Cigarette & Vaporizer Market Research Report - Forecast 2011 to 2021 Report Information More information from: https://www.marketresearchfuture.com/reports/949 Global E-Cigarette & Vaporizer Market Research Report - Forecast 2011 to 2021 Report / Search Code: MRFR/F-B &

More information

A two-microrna signature in urinary exosomes for diagnosis of prostate cancer

A two-microrna signature in urinary exosomes for diagnosis of prostate cancer Poster # B4 A two-microrna signature in urinary exosomes for diagnosis of prostate cancer Anne Karin Ildor Rasmussen 1, Peter Mouritzen 1, Karina Dalsgaard Sørensen 3, Thorarinn Blondal 1, Jörg Krummheuer

More information

NCRI Biomarkers & Imaging CSG Cell-free DNA workshop

NCRI Biomarkers & Imaging CSG Cell-free DNA workshop NCRI Biomarkers & Imaging CSG Cell-free DNA workshop Workshop Report Christie Education Centre, Manchester 30th January 2014 Sponsored by Workshop summary 86 delegates from a variety of specialities attended

More information

Personalized Medicine Disruptive Technology? David Logan Senior Vice President, Commercial Genomic Health Inc

Personalized Medicine Disruptive Technology? David Logan Senior Vice President, Commercial Genomic Health Inc 1 Personalized Medicine Disruptive Technology? David Logan Senior Vice President, Commercial Genomic Health Inc Safe Harbor Statement This presentation contains forward-looking statements within the meaning

More information

BBB_company Brief_2018

BBB_company Brief_2018 BBB_company Brief_2018 BBB Tech creates affordable blood-testing technologies with mobile-enabled tools and data insights. BBB History 2017. 11 Launched elemark TM dual check in Korea 2017. 08 Signed OEM

More information

EU5 Bariatric Surgery Procedures Outlook to 2020

EU5 Bariatric Surgery Procedures Outlook to 2020 EU5 Bariatric Surgery Procedures Outlook to 2020 Reference Code: GDMECR0089PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...

More information

Liquid biopsy, a new tool for cancer experts

Liquid biopsy, a new tool for cancer experts Edition October 2017 Smart Health, Life sciences, CSR Liquid biopsy, a new tool for cancer experts More than 240 cancer specialists gathered in Leuven at the end of August to attend a symposium on liquid

More information

Liquid Biopsy. Jesus Garcia-Foncillas MD PhD. Director

Liquid Biopsy. Jesus Garcia-Foncillas MD PhD. Director Liquid Biopsy Jesus Garcia-Foncillas MD PhD Director Main issues about liquid biopsies New paradigm: Precision Medicine Heterogeneity & Dynamics Surrogate mirror for the tumor CTCs in colon cancer ctdna:

More information

Market Potential for MDX Alcobra Investor Breakfast July 15, 2014

Market Potential for MDX Alcobra Investor Breakfast July 15, 2014 Market Potential for MDX Alcobra Investor Breakfast July 15, 2014 Forward Looking Statement This presentation includes statements that are, or may be deemed, forward-looking statements. In some cases,

More information

Diagnosis of cancer in the UK, and how it might change in future

Diagnosis of cancer in the UK, and how it might change in future Diagnosis of cancer in the UK, and how it might change in future The UK has one of the poorest survival rates of cancer in Western Europe. Treatment given in UK NHS hospitals is possibly among the best

More information

Molecular Cytology That Transforms Patient Care. William Blair 35 th Annual Growth Stock Conference June 9, 2015

Molecular Cytology That Transforms Patient Care. William Blair 35 th Annual Growth Stock Conference June 9, 2015 Molecular Cytology That Transforms Patient Care William Blair 35 th Annual Growth Stock Conference June 9, 2015 Forward-Looking Statements Various remarks that we make in this presentation that are not

More information

The Impact of Ben s Run

The Impact of Ben s Run December 2017 The Impact of Ben s Run AT CHILDREN S NATIONAL HOSPITAL For nearly 150 years, Children s National has been committed to providing exceptional, compassionate care to every child, no matter

More information

Global Diabetic Footwear Market

Global Diabetic Footwear Market Knowledge Based Value (KBV) Research Global Diabetic Footwear Market Market Dynamics Global Diabetic Footwear Market About Global Diabetic Footwear Market The Global Diabetic Footwear Market is expected

More information

REFERENCE CODE GDHC200DFR PUBLICAT ION DATE JUNE 2013 AVASTIN (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC200DFR PUBLICAT ION DATE JUNE 2013 AVASTIN (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC200DFR PUBLICAT ION DATE JUNE 2013 AVASTIN (NON-SMALL CELL LUNG CANCER) AVASTIN (NON-SMALL CELL LUNG CANCER) - Executive Summary Avastin (bevacizumab): Key Metrics in NSCLC Markets 2012

More information

Circulating Cell-Free DNA Pre-analytics: Importance of ccfdna Stabilization and Extraction for Liquid Biopsy Applications

Circulating Cell-Free DNA Pre-analytics: Importance of ccfdna Stabilization and Extraction for Liquid Biopsy Applications Circulating Cell-Free DNA Pre-analytics: Importance of ccfdna Stabilization and Extraction for Liquid Biopsy Applications Martin Schlumpberger, Ass.Director R&D, QIAGEN GmbH IQNpath 2017 - Circulating

More information

Insight into cancer research from discovery to validation

Insight into cancer research from discovery to validation Insight into cancer research from discovery to validation 1 Exosomes in cancer research: from exosome isolation to biomarker discovery Zheng Songyue, PhD Technical Sales Specialists Life Technologies The

More information

January 2017 Investor Presentation. confidently live life with ease

January 2017 Investor Presentation. confidently live life with ease January 2017 Investor Presentation confidently live life with ease Forward-Looking Statements This presentation contains certain forward-looking statements that involve risks and uncertainties that could

More information

View Report Details. Global Coronary Stent Market

View Report Details. Global Coronary Stent Market View Report Details Global Coronary Stent Market ------------------------------------------------- 2013 View Report Details Executive Summary Coronary heart diseases are nowadays becoming more and more

More information

Implantable Defibrillators Market by Product Type [Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter

Implantable Defibrillators Market by Product Type [Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Implantable Defibrillators Market by Product Type [Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), and Cardiac Resynchronization

More information

Comprehensive Chromosome Screening Is NextGen Likely to be the Final Best Platform and What are its Advantages and Quirks?

Comprehensive Chromosome Screening Is NextGen Likely to be the Final Best Platform and What are its Advantages and Quirks? Comprehensive Chromosome Screening Is NextGen Likely to be the Final Best Platform and What are its Advantages and Quirks? Embryo 1 Embryo 2 combine samples for a single sequencing chip Barcode 1 CTAAGGTAAC

More information

Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020

Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Reference Code: GDMECR0107PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3

More information

Global Insulin Pump Market with Focus on United States: Industry Analysis & Outlook ( )

Global Insulin Pump Market with Focus on United States: Industry Analysis & Outlook ( ) Industry Research by Koncept Analytics Global Insulin Pump Market with Focus on United States: Industry Analysis & Outlook ----------------------------------------- (2018-2022) January 2019 1 Executive

More information

REFERENCE CODE GDHC196DFR PUBLICAT ION DATE JUNE 2013 ABRAXANE (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC196DFR PUBLICAT ION DATE JUNE 2013 ABRAXANE (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC196DFR PUBLICAT ION DATE JUNE 2013 ABRAXANE (NON-SMALL CELL LUNG CANCER) Executive Summary Abraxane (nab-paclitaxel): Key Metrics in NSCLC Markets 2012 Abraxane Sales US 5EU $98.34m

More information

Youngnam Cho. National Cancer Center Biomarker Branch

Youngnam Cho. National Cancer Center Biomarker Branch Youngnam Cho National Cancer Center Biomarker Branch Contents 1. Liquid Biopsy 2. Circulating Tumor Cells from Blood 3. Cell-free DNA from Blood 1. Liquid biopsy Cancer Diagnosis IMAGING TISSUE BIOPSY

More information

REFERENCE CODE GDHC472DFR PUBLICAT ION DATE NOVEM BER 2014 STIVARGA (COLORECTAL CANCER) FORECAST AND MARKET ANALYSIS TO 2023

REFERENCE CODE GDHC472DFR PUBLICAT ION DATE NOVEM BER 2014 STIVARGA (COLORECTAL CANCER) FORECAST AND MARKET ANALYSIS TO 2023 REFERENCE CODE GDHC472DFR PUBLICAT ION DATE NOVEM BER 2014 STIVARGA (COLORECTAL CANCER) Executive Summary Table below presents the key metrics for Stivarga for colorectal cancer (CRC) in the eight major

More information

CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS: TECHNOLOGIES AND GLOBAL MARKETS

CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS: TECHNOLOGIES AND GLOBAL MARKETS CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS: TECHNOLOGIES AND GLOBAL MARKETS PHM153A January 2014 Usha Nagavarapu Project Analyst ISBN: 1-56965-671-1 BCC Research 49 Walnut Park, Building 2 Wellesley, MA

More information

vol.3 Highlight Product: ExoCap Product Research tools for extracellular vesicles - Exhibition booth at Taiwan on November

vol.3 Highlight Product: ExoCap Product Research tools for extracellular vesicles - Exhibition booth at Taiwan on November vol.3 Feb. 2018 Highlight Product: ExoCap Product Research tools for extracellular vesicles - Exhibition booth at Taiwan on November Exhibition / Webinar on March 2018 is a big year! CELEBRATE MBL 50th

More information

Circulating tumor cells/dna/etc for Radiation Oncologists

Circulating tumor cells/dna/etc for Radiation Oncologists Circulating tumor cells/dna/etc for Radiation Oncologists Andrew Z. Wang, M.D. Associate Professor Director of Clinical and Translational Research Department of Radiation Oncology Carolina Center for Cancer

More information

HOW TO MAXIMIZE PATIENT RECRUITMENT IN ONCOLOGY TRIALS A BIOPHARMA DIVE PLAYBOOK

HOW TO MAXIMIZE PATIENT RECRUITMENT IN ONCOLOGY TRIALS A BIOPHARMA DIVE PLAYBOOK HOW TO MAXIMIZE PATIENT RECRUITMENT IN ONCOLOGY TRIALS A BIOPHARMA DIVE PLAYBOOK Over the last several decades, patient recruitment for clinical trials has remained a major barrier to rapid execution of

More information

The Interpreting Marketplace

The Interpreting Marketplace The Interpreting Marketplace By Nataly Kelly, Robert G. Stewart, and Vijayalaxmi Hegde June 2010 The Interpreting Marketplace By Nataly Kelly, Robert G. Stewart, and Vijayalaxmi Hegde June 2010 ISBN 978-1-933555-82-9

More information

Dry Eye Syndrome - Current and Future Players. GDHC1016FPR / Published May 2013

Dry Eye Syndrome - Current and Future Players. GDHC1016FPR / Published May 2013 Dry Eye Syndrome - Current and Future Players GDHC1016FPR / Published May 2013 Executive Summary Significant growth is expected in the DES market from 2012-2022. GlobalData estimates 2012 DES therapeutic

More information

ExoQuick Exosome Isolation and RNA Purification Kits

ExoQuick Exosome Isolation and RNA Purification Kits ExoQuick Exosome Isolation and RNA Purification Kits Cat # EQ806A-1, EQ806TC-1, EQ808A-1 User Manual Storage: Please see individual components Version 2 8/14/2018 A limited-use label license covers this

More information

College of American Pathologists

College of American Pathologists College of American Pathologists Comments to the Food and Drug Administration on the draft guidance In Vitro Companion Diagnostics Devices October 12, 2011 College of American Pathologists 1350 I Street,

More information

REFERENCE CODE GDHC1174DFR PUBLICATION DATE M AY 2013

REFERENCE CODE GDHC1174DFR PUBLICATION DATE M AY 2013 REFERENCE CODE GDHC1174DFR PUBLICATION DATE M AY 2013 XELJANZ (PSORIASIS) - Executive Summary Table below presents key metrics for Xeljanz (tofacitinib) in seven of the nine major pharmaceutical markets

More information

Non-Invasive Array Based Screening for Cancer. Dr. Amit Kumar President and CEO CombiMatrix Corporation

Non-Invasive Array Based Screening for Cancer. Dr. Amit Kumar President and CEO CombiMatrix Corporation Non-Invasive Array Based Screening for Cancer Dr. Amit Kumar President and CEO CombiMatrix Corporation www.combimatrix.com May 13, 2009 This presentation contains forward-looking statements within the

More information

REFERENCE CODE GDHC357DFR PUBLICAT ION DATE FEBRUARY 2014 CLOZARIL (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC357DFR PUBLICAT ION DATE FEBRUARY 2014 CLOZARIL (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC357DFR PUBLICAT ION DATE FEBRUARY 2014 CLOZARIL (SCHIZOPHRENIA) Executive Summary Clozaril: Key Metrics in the Seven Major Pharmaceutical Markets, 2012 2022 2012 Market Sales US 5EU

More information